Last reviewed · How we verify
NCT06185894: SPARTACUS
Single-step Placenta Accreta Resective Technique Tourniqueted vs Absence, Conservative Uterine Surgery
NA trial testing Uterovesical tourniquet before uterine devascularization steps in Placenta Accreta in 40 participants. Currently enrolling.
30 June 2024
Quick facts
| Lead sponsor | Cairo University |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 October 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Uterovesical tourniquet before uterine devascularization steps
- Conventional conservative surgery
Conditions studied
- Placenta Accreta — all drugs for Placenta Accreta →
Sponsor
Cairo University
Who can join
Adults 20 to 40, female only, with Placenta Accreta. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: An optimal international standard for PAS surgery is not yet available, and the establishment of a suitable surgical method is an important focus of in PAS management. Objective: To assess the efficacy and safety of tourniquet uses for conservative approach in the management of placenta accerta spectrum. Patients and Methods: 40 pregnant women who underwent conservative management of placenta accrete at Kasr El-Aini hospital (Obstetrics and gynecology department - Faculty of medicine - Cairo university) were included and were divided according to the use of tourniquet into 2 equal groups: Study group (tourniquet group): consists of 20 women for whom tourniquet was used in the lower part of the uterus during surgical treatment of placenta accreta spectrum.Control group (no tourniquet group): consists of 20 women for whom no tourniquet was used.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Uterovesical tourniquet for conservative management of placenta accreta spectrum: a prospective cohort study in a low-resource setting.
Mousa A, Gaafar HM, Abdullah M, Elsherbini MM, et al · · 2025 · PMID 41387818 · DOI 10.1186/s12884-025-08381-7
Verify or expand the search:
- PubMed search for NCT06185894
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Placenta Accreta
Currently open trials in the same condition.
- NCT07283042 — Evaluation of Clinical Outcomes and Acceptability of an Anatomical Classification for Placenta Accreta Spectrum · recruiting
- NCT06465836 — Simplified Conservative Measures in Managing Morbidly Adherent Placenta in Beni-Suef University · NA · recruiting
- NCT06833606 — Diagnosis and Outcomes of Placental Accretism · recruiting
- NCT05922397 — Placenta Accreta Spectrum Topographic Classification · recruiting
- NCT05139498 — Conservative Management for PAS Pilot · NA · active not recruiting
Other Cairo University trials
Trials by the same sponsor.
- NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
- NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
- NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
- NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
- NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06185894 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cairo University
- Last refreshed: 4 June 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06185894.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing